510(k) K053603
K053603 is an FDA 510(k) premarket notification submitted by Roche Diagnostics Corp. for the device "C-REACTIVE PROTEIN (LATEX) HIGH SENSITIVE TEST SYSTEM FOR COBAS INTEGRA INSTRUMENTS". The FDA issued a decision of Substantially Equivalent on Feb 9, 2006. The device falls under product code NQD (Cardiac C-Reactive Protein, Antigen, Antiserum, And Control), a Class II device regulated under 21 CFR 866.5270. Roche Diagnostics Corp. has 456 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 9, 2006
- Date Received
- Dec 23, 2005
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
- Device Class
- Class II
- Regulation Number
- 866.5270
- Review Panel
- IM
- Submission Type
- 510(k)
In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments.
Need the full FDA record for Roche Diagnostics Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.